1 Reason Wall Street Is Obsessed With Vertex Pharmaceuticals

Key Points Vertex Pharmaceuticals has a lot of buy and hold ratings, but there aren't any sell ratings from Wall Street analysts. Around 75,000 people with cystic fibrosis rely on Vertex Pharmaceuticals to keep their lungs functioning. There are no other drugmakers marketing treatments that correct the misformed proteins responsible for cystic fibrosis. 10 stocks we like better than Vertex Pharmaceuticals › Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) have risen more than 2,000% over the past ...